- Home
- ARTW vs CRIS Comparison
ARTW vs CRIS Comparison
Compare ARTW & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARTW
- CRIS
- Stock Information
- Founded
- ARTW 1956
- CRIS 2000
- Country
- ARTW United States
- CRIS United States
- Employees
- ARTW N/A
- CRIS N/A
- Industry
- ARTW Industrial Machinery/Components
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ARTW Industrials
- CRIS Health Care
- Exchange
- ARTW Nasdaq
- CRIS Nasdaq
- Market Cap
- ARTW 23.5M
- CRIS 22.9M
- IPO Year
- ARTW N/A
- CRIS 2000
- Fundamental
- Price
- ARTW $3.15
- CRIS $1.71
- Analyst Decision
- ARTW
- CRIS Strong Buy
- Analyst Count
- ARTW 0
- CRIS 2
- Target Price
- ARTW N/A
- CRIS $16.50
- AVG Volume (30 Days)
- ARTW 75.0K
- CRIS 72.5K
- Earning Date
- ARTW 10-03-2025
- CRIS 08-05-2025
- Dividend Yield
- ARTW N/A
- CRIS N/A
- EPS Growth
- ARTW N/A
- CRIS N/A
- EPS
- ARTW 0.44
- CRIS N/A
- Revenue
- ARTW $23,523,353.00
- CRIS $11,405,000.00
- Revenue This Year
- ARTW N/A
- CRIS $1.41
- Revenue Next Year
- ARTW N/A
- CRIS $7.46
- P/E Ratio
- ARTW $9.24
- CRIS N/A
- Revenue Growth
- ARTW N/A
- CRIS 12.24
- 52 Week Low
- ARTW $1.43
- CRIS $1.02
- 52 Week High
- ARTW $4.71
- CRIS $6.44
- Technical
- Relative Strength Index (RSI)
- ARTW 47.43
- CRIS 50.40
- Support Level
- ARTW $2.96
- CRIS $1.63
- Resistance Level
- ARTW $3.43
- CRIS $1.95
- Average True Range (ATR)
- ARTW 0.32
- CRIS 0.14
- MACD
- ARTW -0.06
- CRIS 0.02
- Stochastic Oscillator
- ARTW 26.25
- CRIS 50.00
About ARTW Art's-Way Manufacturing Co. Inc.
Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products, and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.